Skip to main content

Advertisement

Fig. 4 | BMC Cancer

Fig. 4

From: Interleukin 8 is a biomarker of telomerase inhibition in cancer cells

Fig. 4

IL8 levels decrease upon inhibition of telomerase. Indicated cells were treated with imetelstat for 2 weeks. a IL8 RNA level was measured by qRT-PCR. Actin was used as internal control. Relative levels with respect to control mismatch oligonucleotide treated cell is plotted. b IL8 protein level was measured by immunoblotting. Actin was used as loading control. Error bar shows Standard Error Mean (SEM). (*, p < 0.01)

Back to article page